Tianjin Chase Sun Pharmaceutical Co., Ltd. Class A (300026.SZ) SHZ
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 10.57B |
| Enterprise Value | 9.61B |
| P/E Ratio | 381.93 |
| PEG Ratio | -0.12 |
| Price/Sales Ratio | 2.04 |
| Price/Book Ratio | 1.21 |
| Enterprise/Revenue | 1.81 |
| Enterprise/EBITDA | 25.21 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.01 |
| Operating Margin | 0.03 |
AD
Management Effectiveness
| Return On Assets | 0 |
| Return On Equity | 0 |
Income Statement
| Revenue | 4.9B |
| Revenue/Share | 1.42 |
| Gross Profit | 2.65B |
| EBITDA | 466M |
| Net Income | 18.5M |
| Diluted EPS | 0.01 |
Balance Sheet
| Total Cash | 1.56B |
| Total Cash/Share | 0.47 |
| Total Debt | 516.04M |
| Total Debt/Equity | 0.06 |
| Current Ratio | 4.7 |
| Book Value Per Share | 2.65 |
Price History
| 52-Week Change | -20.35 |
| 52-Week High | 4.49 |
| 52-Week Low | 2.82 |
| Moving Average 50 Days | 3.19 |
| Moving Average 200 Days | 3.53 |
Statistics
| Average Volume | 33.38M |
| Shares Outstanding | 3B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.03 |
| Trailing Annual Dividend Yield | 0.95 |
| Payout Ratio | 7.75 |
| Last Split Factor | 3:1 |
| Last Split Date | October 26, 2016 |
AD
